A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA)

PURPOSE: We report our experience with the use of the matrix regenerating agent (RGTA) Cacicol(®) after reverse transepithelial all-surface laser ablation (ASLA)-SCHWIND to assess the safety, efficacy, pain, and epithelial healing. METHODS: Forty eyes of 20 myopic patients were prospectively recruit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Ophthalmol
Hlavní autoři: Aslanides, Ioannis M, Selimis, Vasilis D, Bessis, Nikolaos V, Georgoudis, Panagiotis N
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404873/
https://ncbi.nlm.nih.gov/pubmed/25931809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S81061
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky